HOME >> BIOLOGY >> NEWS
Vitamin D3 provides the skin with protection from harmful microbes

Skin wounds breach the physical barrier that protects the body from harmful microbes in the environment. To counter this breach, wounding triggers an immune response that includes the production of antimicrobial peptides and the upregulation of receptors that recognize microbial components. However, the factors that trigger this immune response have not been well defined.

In a study appearing online on February 8 in advance of publication in the March print issue of the Journal of Clinical Investigation, Richard Gallo and colleagues from the University of California at San Diego now show that wounding to the skin of humans triggers the production (by skin cells known as keratinocytes) of the active form of vitamin D3, and that this induces increased expression of the antimicrobial peptide cathelicidin and the microbial recognition receptors TLR2 and CD14. Further analysis showed that wounding induced keratinocyte expression of the enzyme responsible for converting inactive vitamin D3 to active vitamin D3 (CYP27B1) and that this could be recapitulated in vitro by culturing keratinocytes in the presence of the soluble factor TGF-beta-1. The authors therefore suggest that soluble factors present in wounds, such as TGF-beta-1, induce the expression of CYP27B1, which enables keratinocytes to produce active vitamin D3 that, in turn, induces the upregulation of some components of the immune response and protects us from harmful microbes.


'"/>

Contact: Karen Honey
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
8-Feb-2007


Page: 1

Related biology news :

1. Vitamin extends life in yeast, Dartmouth Medical School researchers find
2. Vitamin D, variations in its receptor and prostate cancer
3. Vitamin D deficiency widespread during pregnancy
4. Vitamin C and water not just healthy for people -- healthy for plastics, too
5. Vitamin D may cut pancreatic cancer risk by nearly half
6. Vitamin D and flavonoids examined for impact on breast and ovarian cancers
7. Nutritional friend or foe? Vitamin E sends mixed messages
8. Vitamin A analog is a potential lung cancer preventative with few side effects
9. Vitamin supplement could help treatment-resistant asthma
10. Vitamin As paradoxical role in influencing symmetry during embryonic development revealed
11. Vitamin E loss through smoking increases health risks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... solutions for biopharmaceutical R&D, today announced that it has entered into a ... multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy to ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions ... data services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: ... hospitalized patients with severe COVID-19. This is the first study of an XPO1 ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... cold chain validation engineering firm, is making available for free its new ... to incorporate concurrent transport simulation testing into today’s biologics licensing application (BLA). ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, ... its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes at ... requiring fast track capacity to provide patients with urgently needed vaccines and other ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. (Nasdaq: ... advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene ... strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical ...
Breaking Biology Technology:
Cached News: